Hydrophobic Interaction Chromatography Market Share

North American Market Forecast

The North America hydrophobic interaction chromatography market is projected to be the largest with a share of about 35% by the end of 2036. Growing cases of cancer and autoimmune diseases are driving the market growth. In 2022, the United States recorded around 1,918,030 new cancer cases and nearly 609,360 cancer deaths. Monoclonal antibodies are commonly utilized in cancer therapy. HIC allows for the production of high-purity mAB, which is employed in cancer therapy.

European Market Statistics

The European hydrophobic interaction chromatography market is estimated to be the second largest, registering a share of about 28% by the end of 2036. The presence of the leading biopharma companies leads to the higher discovery of therapies and results in higher demand for the HIC for better output of these drugs. Many of the world's biggest pharmaceutical companies have their base in Europe, including Novartis, Roche, Bayer, Novo Nordisk, AstraZeneca, Sanofi, GSK, and many others.

Frequently Asked Questions (FAQ)

In the year 2024, the industry size of hydrophobic interaction chromatography is assessed at USD 1.69 Billion.

The hydrophobic interaction chromatography market size was valued at USD 1.54 Billion in 2023 and is likely to reach USD 5.62 Billion by the end of 2036, registering around 10.5% CAGR during the forecast period i.e., between 2024-2036. Rising development of vaccines and higher investment in biopharma industries are the major factors driving the market growth.

North America industry is projected to hold 35% of the revenue share by 2036, impelled by growing cases of cancer and autoimmune diseases in the region.

Sunresin New Materials Co., Ltd.Bio-Rad Laboratories, Inc.Thermo Fisher ScientificThe General Electric CompanySartorius AGTosoh Bioscience, Inc.Sepax Technologies, Inc.Merck KGaA.JNC CorporationGeno Technology Inc.

Hydrophobic Interaction Chromatography Market Share